Today, biotech stocks are showing significant movements. For instance, the NASDAQ Biotechnology Index (NBI) experienced a decline, attributed to various market factors, including investor sentiment and upcoming FDA decisions on drug approvals​(

Nasdaq). Companies like BioNTech have recently seen fluctuations, partly due to news on new cancer treatment trials​(

Nasdaq). Overall, analysts suggest that while some stocks have faced challenges, the sector shows potential for recovery and growth, particularly with advancements in drug development and biotech innovations​(

Nasdaq).

For detailed stock performance and specific companies, you can check Yahoo Finance.